BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17686442)

  • 1. Optimising survival in malignant mesothelioma.
    Baas P
    Lung Cancer; 2007 Aug; 57 Suppl 2():S24-9. PubMed ID: 17686442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?
    Rusch VW
    J Clin Oncol; 2003 Jul; 21(14):2629-30. PubMed ID: 12860935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant pleural mesothelioma in 1997].
    Viallat JR; Boutin C; Kasseyet S
    Schweiz Med Wochenschr; 1997 Oct; 127(41):1707-11. PubMed ID: 9441378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.
    Halstead JC; Lim E; Venkateswaran RM; Charman SC; Goddard M; Ritchie AJ
    Eur J Surg Oncol; 2005 Apr; 31(3):314-20. PubMed ID: 15780570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts in malignant pleural mesothelioma.
    Kaufman AJ; Pass HI
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging and response to therapy of malignant pleural mesothelioma.
    Heelan R
    Lung Cancer; 2004 Aug; 45 Suppl 1():S59-61. PubMed ID: 15261435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the systemic therapy of malignant pleural mesothelioma.
    Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
    Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical staging and work-up of patients with diffuse malignant pleural mesothelioma.
    Sugarbaker DJ; Norberto JJ; Swanson SJ
    Semin Thorac Cardiovasc Surg; 1997 Oct; 9(4):356-60. PubMed ID: 9352952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis by intrapleural perfusion hyperthermo-chemotherapy for malignant pleural mesothelioma.
    Matsuzaki Y; Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2008 Jun; 14(3):161-5. PubMed ID: 18577894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.
    Jassem J; Ramlau R; Santoro A; Schuette W; Chemaissani A; Hong S; Blatter J; Adachi S; Hanauske A; Manegold C
    J Clin Oncol; 2008 Apr; 26(10):1698-704. PubMed ID: 18375898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and staging of malignant pleural mesothelioma].
    Sohrab S; Konietzko N
    Pneumologie; 2002 Jun; 56(6):382-7. PubMed ID: 12063622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First-line treatment with pemetrexed in association with cisplatin in patients with non-operable malignant pleural mesothelioma].
    Burgin M; Gairard-Dory A-; Mennecier B; Molard A; Beretz L; Quoix A-
    Rev Pneumol Clin; 2009 Apr; 65(2):75-83. PubMed ID: 19375046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
    Li L; Razak AR; Hughes A
    Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of survival time in malignant pleural mesothelioma?].
    Habacher W
    Med Klin (Munich); 2003 Jan; 98(1):59; author reply 59-60. PubMed ID: 12596698
    [No Abstract]   [Full Text] [Related]  

  • 16. Current options for systemic therapy in mesothelioma.
    Jackman DM
    Semin Thorac Cardiovasc Surg; 2009; 21(2):154-8. PubMed ID: 19822287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant pleural mesothelioma: surgical management in 285 patients.
    Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
    Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
    Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant mesothelioma of the pleura: place of surgery].
    Giudicelli R; Regnard JF; Astoul P; Ruffie P
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S106-10S109. PubMed ID: 17127980
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?
    Nakas A; Black E; Entwisle J; Muller S; Waller DA
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1457-63. PubMed ID: 20138534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.